iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
Anti-Fibrotic Activity of Oral, Dual CCR2 and CCR5 Antagonist Cenicriviroc in a Mouse Model of NASH and a Rat Model of TAA-Induced Liver Fibrosis
 
 
  Reported by Jules Levin
HepDart Dec 9-12 2013, Hawaii
 
S.L. Friedman1, H. Chou1, T. Hashiguchi2, F. Hong1, H. Jenkins3, G.H.I. Wolfgang4, H. Yoneyama2, E. Lefebvre3 1Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, NY, USA, 2Stelic Institute & Co., Tokyo, Japan, 3Tobira Therapeutics, Inc., San Francisco, CA, USA, 4Kailua-Kona, HI, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

Figure2.gif

AASLD5.gif

Fig4.gif

AASLD7.gif

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org